Now, as the Shoklo Malaria Research Unit (SMRU) in Mae Sot, Thailand, celebrates its twentieth anniversary, Nosten, who was recently awarded a professorship by the University of Oxford, is able to reflect on the success of the unit, which is based amongst the region's refugee camps. The currently recommended malaria therapies (based on drug combinations including an artemisinin derivative) are the result of research carried out at SMRU, which is part of the Wellcome Trust's Major Overseas Programme in Thailand. Professor Nosten is amongst the top ten most-cited researchers in malaria research and has been a key player in the fight against drug-resistant strains of the parasite.
The Shoklo Malaria Research Unit, now part of -the Faculty of Tropical Medicine, Mahidol University, came into being when François met Nick White, then with the Wellcome Trust's Thailand programme (now Chairman of the SE Asia Overseas Programme in Thailand and Vietnam). White was looking for a field unit to study malaria. At the time, Nosten was a medical volunteer with the international humanitarian aid organization Médecins Sans Frontières.
"The original unit was very basic," explains Professor Nosten. "We set it up in my home, with a lab on the ground floor, complete with a centrifuge and one microscope for analysis of blood samples."
In 1989 the research unit moved to Shoklo, the largest of the refugee camps on the border of Thailand and Burma, where 9,000 Karen refugees from across the border were housed. The focus of the research was to study the efficacy of malaria drug treatments in pregnant women and in children.
The unit was forced to move to its current location in Mae Sot in 1996 one year after an attack by guerrillas from the Democratic Karen Buddhist Army, targeting foreign aid workers in an attempt to force the refugees to return to Burma. During the attack, Professor Nosten and his colleague Rose McGready had been forced to hide in the jungle.
Now, Professor Nosten is assisted in his work by Thai nationals from the region, including a number of local Karen and Burmese who received training by the SMRU team. In addition to studying malaria drug treatments for pregnant women, the unit has carried out crucial research into artemisinin combination therapies (ACTs) aimed at combating the rapid rise in drug-resistance. The unit has carried out the largest number of drug trials in malaria and research at the unit has been influential in changing WHO guidelines for malaria drug treatment.
"The work at Shoklo has been very successful, and together with NGOs and the Thai government, we have managed to reduce the incidence of infection by the most deadly form of malaria by over 90% in the camps and the surrounding regions," says Professor Nosten. However, he cautions, it will likely prove almost impossible to eradicate infections completely.
"At the treatment centres, we deal with a large number of migrant workers from Burma, crossing the border for work and returning to their families when they have finished," he explains. "If an infected worker crosses the border, they will bring with them the parasite, so perpetuating the cycle of transmission from humans to mosquitoes."
The reduction in the number of malaria cases has allowed the unit to focus on other health issues such as respiratory diseases. In addition, a surveillance network established in 1995 to monitor malaria infection in the camps along the border has now received funding to track the development of the avian influenza virus.
"We would like to congratulate François and his team," says Dr Mark Walport, Director of the Wellcome Trust. The Trust, along with Oxford University, has funded the SMRU since its inception. "Their work, often in difficult circumstances, has made a huge impact on the fight against malaria, not only in the region but also globally. François has shown dedication and a determination which is to be applauded."
The SMRU will be hosting a scientific seminar in Mae Sot on 28 December entitled "Twenty Years of Malaria Research: Outcomes and Perspectives" attended by internationally-renowned experts and featuring talks and debates on a variety of topics related to malaria, from epidemiology to therapeutics and from immunity to socio-economics.
Craig Brierley | alfa
Potential seen for tailoring treatment for acute myeloid leukemia
10.12.2018 | University of Washington Health Sciences/UW Medicine
UC San Diego researchers develop sensors to detect and measure cancer's ability to spread
06.12.2018 | University of California - San Diego
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals
Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.
Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.
Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...
Scientists from the Theory Department of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science (CFEL) in Hamburg have shown through theoretical calculations and computer simulations that the force between electrons and lattice distortions in an atomically thin two-dimensional superconductor can be controlled with virtual photons. This could aid the development of new superconductors for energy-saving devices and many other technical applications.
The vacuum is not empty. It may sound like magic to laypeople but it has occupied physicists since the birth of quantum mechanics.
10.12.2018 | Event News
06.12.2018 | Event News
03.12.2018 | Event News
10.12.2018 | Life Sciences
10.12.2018 | Physics and Astronomy
10.12.2018 | Life Sciences